단백질체학 시장 : 기술, 기기 유형, 서비스, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Proteomics Market was valued at USD 31.78 billion in 2023, expected to reach USD 36.05 billion in 2024, and is projected to grow at a CAGR of 14.67%, to USD 82.90 billion by 2030.

Proteomics, an extensive field of study of proteins, their structures, and functions, is crucial in understanding biological processes and mechanisms. At its core, the scope of proteomics extends from identifying proteins to analyzing their interactions, helping drive advances in personalized medicine and drug discovery. The necessity of proteomics lies in its potential to unravel complex cellular functions, offering deeper insights into disease mechanisms and the effectiveness of therapeutic interventions. Its applications span clinical diagnostics, biomarker discovery, and systems biology, with end-use sectors including pharmaceuticals, biotechnology, and academic research. Market insights indicate that key growth factors include advancements in mass spectrometry technology, increasing research activities in drug discovery, and rising demand for personalized medicine. Potential opportunities abound, such as developing next-generation proteomics technologies, expanding into untapped emerging markets, and forging strategic partnerships to enhance R&D capabilities. To seize these opportunities, businesses should focus on developing cost-effective and high-throughput technologies while simultaneously advocating for increased funding and collaboration in the proteomics field. However, the market also faces limitations, such as the high cost of instruments and technical complexity, which pose significant barriers to broader adoption. Fragmentation in standardization, lack of skilled personnel, and data management challenges further complicate growth prospects. Despite these challenges, promising areas for innovation include integrating proteomics with genomics and other omics domains, developing AI-driven data analysis tools, and enhancing method standardization to improve reproducibility. The proteomics market is inherently dynamic and competitive, characterized by rapid technological innovations and constant evolution, making it essential for players to maintain agile strategies to address challenges and meet emerging demands. To remain competitive, companies should commit to continuous investment in R&D, foster interdisciplinary collaborations, and prioritize customer-centric approaches that align with evolving market needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Proteomics Market

The Proteomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use in cancer treatment and need for personalized medicine
  • Rise in adoption of bioinformatics software & services for proteomics studies
  • Government initiatives for human proteome organization and proteomics standards
• Market Restraints
  • High cost associated with proteomics data repository management
• Market Opportunities
  • Significant investment in research & developments of proteomics technique
  • Emerging investments in proteomics biomarker discovery
• Market Challenges
  • Peptide identification limitations in proteomics

Porter's Five Forces: A Strategic Tool for Navigating the Proteomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Proteomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Proteomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Proteomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Proteomics Market

A detailed market share analysis in the Proteomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Proteomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Proteomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Proteomics Market

A strategic analysis of the Proteomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Proteomics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biomics, Inc., Bio-Rad Laboratories, Inc., Biognosys AG, Bruker Corporation, Cellenion SASU by Bico Group AB, Charles River Laboratories, Inc., Creative Biolabs, Inc., Creative Proteomics, Danaher Corporation, GE Healthcare, Illumina, Inc., IsoPlexis Corporation, Luminex Corporation, Merck KGaA, MRM Proteomics, Inc., Nautilus Biotechnology Inc., NEO Proteomics, Inc., Olink Holding AB, Perkinelmer, Inc., Poochon Scientific, LLC, Precision Proteomics Inc., Promega Corporation, PROMISE Proteomics, Proteome Sciences PLC, Proteomics International, Shantani Proteome Analytics Pvt. Ltd., Thermo Fisher Scientific, Inc., VProteomics, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Proteomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Chromatography, Edman Sequencing, Electrophoresis, Mass Spectrometry, Protein Fractionation, Protein Microarrays, Surface Plasmon Resonance, and X Ray Crystallography. The Chromatography is further studied across Affinity Chromatography, Gas Chromatography, Ion Chromatography, Liquid Chromatography, and Superficial Chromatography. The Electrophoresis is further studied across Capillary Electrophoresis and Gel Electrophoresis. The Mass Spectrometry is further studied across Fourier Transform Mass Spectrometry and Tandem Mass Spectrometry. The Protein Microarrays is further studied across Biochip and Functional Protein Microarray.
• Based on Instrument Type, market is studied across Analytical Instruments, Reagents & Consumables, and Software. The Analytical Instruments is further studied across Chromatography Instruments and Spectrometers. The Reagents & Consumables is further studied across Buffers and Stains & Dyes. The Software is further studied across Bioinformatics Databases, Bioinformatics Tools, Data Acquisition Software, and Data Analysis Software.
• Based on Services, market is studied across Bioinformatics Services and Core Proteomics Services.
• Based on Application, market is studied across Biomarker Identification, Clinical Diagnostics, and Drug Discovery. The Biomarker Identification is further studied across Cancer Biomarkers and Cardiovascular Biomarkers. The Clinical Diagnostics is further studied across Disease Diagnosis and Therapeutic Drug Monitoring. The Drug Discovery is further studied across Lead Compound Identification and Target Identification.
• Based on End User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Centers, and Pharmaceutical Companies. The Academic & Research Institutes is further studied across Core Research Facilities and University Labs. The Hospital & Diagnostic Centers is further studied across Clinical Testing Departments and Pathology Labs. The Pharmaceutical Companies is further studied across Drug Manufacturing Unit and R&D Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use in cancer treatment and need for personalized medicine
    • 5.1.1.2. Rise in adoption of bioinformatics software & services for proteomics studies
    • 5.1.1.3. Government initiatives for human proteome organization and proteomics standards
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with proteomics data repository management
  • 5.1.3. Opportunities
    • 5.1.3.1. Significant investment in research & developments of proteomics technique
    • 5.1.3.2. Emerging investments in proteomics biomarker discovery
  • 5.1.4. Challenges
    • 5.1.4.1. Peptide identification limitations in proteomics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Rising demand for chromatography due to the precision and reliability
  • 5.2.2. Application: Utilization of proteomics in clinical diagnostics for early disease detection, prognosis, and personalized treatment strategies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Proteomics Market, by Technology

• 6.1. Introduction
• 6.2. Chromatography
  • 6.2.1. Affinity Chromatography
  • 6.2.2. Gas Chromatography
  • 6.2.3. Ion Chromatography
  • 6.2.4. Liquid Chromatography
  • 6.2.5. Superficial Chromatography
• 6.3. Edman Sequencing
• 6.4. Electrophoresis
  • 6.4.1. Capillary Electrophoresis
  • 6.4.2. Gel Electrophoresis
• 6.5. Mass Spectrometry
  • 6.5.1. Fourier Transform Mass Spectrometry
  • 6.5.2. Tandem Mass Spectrometry
• 6.6. Protein Fractionation
• 6.7. Protein Microarrays
  • 6.7.1. Biochip
  • 6.7.2. Functional Protein Microarray
• 6.8. Surface Plasmon Resonance
• 6.9. X Ray Crystallography

7. Proteomics Market, by Instrument Type

• 7.1. Introduction
• 7.2. Analytical Instruments
  • 7.2.1. Chromatography Instruments
  • 7.2.2. Spectrometers
• 7.3. Reagents & Consumables
  • 7.3.1. Buffers
  • 7.3.2. Stains & Dyes
• 7.4. Software
  • 7.4.1. Bioinformatics Databases
  • 7.4.2. Bioinformatics Tools
  • 7.4.3. Data Acquisition Software
  • 7.4.4. Data Analysis Software

8. Proteomics Market, by Services

• 8.1. Introduction
• 8.2. Bioinformatics Services
• 8.3. Core Proteomics Services

9. Proteomics Market, by Application

• 9.1. Introduction
• 9.2. Biomarker Identification
  • 9.2.1. Cancer Biomarkers
  • 9.2.2. Cardiovascular Biomarkers
• 9.3. Clinical Diagnostics
  • 9.3.1. Disease Diagnosis
  • 9.3.2. Therapeutic Drug Monitoring
• 9.4. Drug Discovery
  • 9.4.1. Lead Compound Identification
  • 9.4.2. Target Identification

10. Proteomics Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
  • 10.2.1. Core Research Facilities
  • 10.2.2. University Labs
• 10.3. Hospital & Diagnostic Centers
  • 10.3.1. Clinical Testing Departments
  • 10.3.2. Pathology Labs
• 10.4. Pharmaceutical Companies
  • 10.4.1. Drug Manufacturing Unit
  • 10.4.2. R&D Laboratories

11. Americas Proteomics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Proteomics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Proteomics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. SPOC Proteomics launched customizable SPOC biosensors for beta testing, announcing breakthrough SPR technology set to transform proteomics
  • 14.3.2. Bruker launched timsTOF Ultra 2, a state-of-the-art mass spectrometry device enhancing single-cell proteomics with advanced software integration
  • 14.3.3. Biognosys and Alamar Biosciences partner to integrate NULISA assays and enhance DIA-MS platform for advanced proteomics research
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Applied Biomics, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Biognosys AG
• 5. Bruker Corporation
• 6. Cellenion SASU by Bico Group AB
• 7. Charles River Laboratories, Inc.
• 8. Creative Biolabs, Inc.
• 9. Creative Proteomics
• 10. Danaher Corporation
• 11. GE Healthcare
• 12. Illumina, Inc.
• 13. IsoPlexis Corporation
• 14. Luminex Corporation
• 15. Merck KGaA
• 16. MRM Proteomics, Inc.
• 17. Nautilus Biotechnology Inc.
• 18. NEO Proteomics, Inc.
• 19. Olink Holding AB
• 20. Perkinelmer, Inc.
• 21. Poochon Scientific, LLC
• 22. Precision Proteomics Inc.
• 23. Promega Corporation
• 24. PROMISE Proteomics
• 25. Proteome Sciences PLC
• 26. Proteomics International
• 27. Shantani Proteome Analytics Pvt. Ltd.
• 28. Thermo Fisher Scientific, Inc.
• 29. VProteomics
• 30. Waters Corporation